Su valor como predictor de diabetes de tipo 2 | 21 MAR 06

Importancia de la glucemia normal alta en ayunas en hombres jóvenes

Pueden predecir la aparición de diabetes de tipo 2 e indicar el inicio de intervenciones preventivas.
Autor/a: Dres. Amir Tirosh, Iris Shai, Dorit Tekes-Manova, Eran Israeli Fuente: Comentario y resumen objetivo: Dra. Marta Papponetti Diabetes in Young Men. N Engl J Med. 2005;353:1454-62.
INDICE:  1. Desarrollo | 2. Bibliografía
Bibliografía
1. Genuth S, Alberti KG, Bennett P, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care 2003;26:3160-7.

2. Genuth S. Lowering the criterion for impaired fasting glucose is in order. Diabetes Care 2003;26:3331-2.

3. Borch-Johnsen K, Colagiuri S, Balkau B, et al. Creating a pandemic of prediabetes: the proposed new diagnostic criteria for impaired fasting glycaemia. Diabetologia  2004;47:1396-402.

4. Piche ME, Arcand-Bosse JF, Despres JP, Perusse L, Lemieux S, Weisnagel SJ. What is a normal glucose value? Differences in indexes of plasma glucose homeostasis in subjects with normal fasting glucose. Diabetes Care 004;27:2470-7.

5. Tai ES, Goh SY, Lee JJ, et al. Lowering the criterion for impaired fasting glucose: impact on disease prevalence and associated risk of diabetes and ischemic heart disease. Diabetes Care  2004;27:1728-34.

6. Schriger DL, Lorber B. Lowering the cut point for impaired fasting glucose: where is the evidence? Where is the logic? Diabetes Care 2004;27:592-601.

7. Bortheiry AL, Malerbi DA, Franco LJ. The ROC curve in the evaluation of fasting capillary blood glucose as a screening test for diabetes and IGT. Diabetes Care 1994; 17:1269-72.

8. Gabir MM, Hanson RL, Dabelea D, et al. The 1997 American Diabetes Association and 1999 World Health Organization criteria for hyperglycemia in the diagnosis and prediction of diabetes. Diabetes Care 2000;23: 1108-12.

9. Shaw JE, Zimmet PZ, Hodge AM, et al. Impaired fasting glucose: how low should it go? Diabetes Care 2000;23:34-9.

10. Bloomgarden ZT. Type 2 diabetes in the young: the evolving epidemic. Diabetes Care 2004;27:998-1010.

11. Chiasson JL, Josse RG, Gomis R, et al. Acarbose for preve
 

Comentarios

Para ver los comentarios de sus colegas o para expresar su opinión debe ingresar con su cuenta de IntraMed.

CONTENIDOS RELACIONADOS
AAIP RNBD
Términos y condiciones de uso | Política de privacidad | Todos los derechos reservados | Copyright 1997-2024